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Abstract 
Objectives: To investigate the incidence and factors influencing radial artery occlusion 
(RAO) post trans-radial access (TRA) for cardiac catheterization. 
Background: RAO may occur post trans-radial intervention and limits the radial artery as a 
future access site and precludes its use as an arterial conduit. In this study, we investigate the 
incidence and factors influencing the RAO in the current literature. 
Methods & Results: We searched MEDLINE and EMBASE for studies of RAO in TRA.  
Relevant studies were identified and data was extracted.  Data was synthesized by meta-
analysis, quantitative pooling, graphical representation or by narrative synthesis. 
A total of 66 studies with 31,345 participants were included in the analysis. Incident RAO 
ranged between <1% to 33% and varied with timing of assessment of radial artery patency 
(incidence of RAO within 24 hours was 7.7% which decreased to 5.5% at greater than 1 week 
follow up). The most efficacious measure in reducing RAO was higher dose of heparin as 
lower doses of heparin were associated with increased RAO (RR 0.36, 95%CI 0.17-0.76) 
whilst shorter compression times also reduced RAO (RR 0.28, 95%CI 0.05-1.50). Several 
factors were found to be associated with RAO including age, gender, sheath size and 
diameter of radial artery but these factors were not consistent across all studies. 
Conclusions: RAO is a common complication of TRA. Maintenance of radial patency 
should be an integral part of all procedures undertaken through the radial approach. High 
dose heparin along with shorter compression times and patent hemostasis is recommended in 
reducing radial artery occlusion.  
 
Keywords: Radial artery occlusion, transradial catheterization or access, vascular 
complications
Introduction 
 Trans radial access (TRA) has grown to become the default access site in the UK (1-
4) Europe and Asia (5) and is rapidly growing in the USA. (6-8) Compared with transfemoral 
access (TFA), TRA has been shown to reduce mortality and adverse cardiac events even in 
high-risk patient groups, (3,9) reduced major bleeding and access site related vascular 
complications (10) and patient discomfort, allows early mobilization and reduced procedure 
related costs. (11,12) However, TRA is not without challenges and complications. TRA is 
technically more difficult with a longer learning curve and is associated with radial artery 
spasm and radial artery occlusion, (RAO) particularly in females and elderly patients. (13,14) 
 RAO is quiescent complication of TRA that rarely leads to critical hand ischemia 
requiring intervention owing to the dual vascular supply of hand from palmar arch. RAO is 
often overlooked and in fact more than 50% of operators do not even assess radial artery 
patency before discharge. (15) Once occluded, future use radial artery as an access site for 
PCI, as a conduit for coronary bypass grafting or fistula formation in hemodialysis patients is 
precluded.  The reported incidence of RAO varies widely from 0.8% to as high as 38% in the 
published data. (16-20) Studies have reported that baseline patient characteristics such as 
body mass index and diabetes may influence RAO. (21) A number of procedural variables 
such as sheath size, (22) use of anticoagulants, (18,23) and patent hemostasis (18) have also 
been shown to reduce the incidence of RAO.   
 Many studies have evaluated the incidence and risk factors for RAO with several 
studies assessing interventions to reduce its likelihood. However, there has yet to be a 
systematic review that collectively synthesizes the evidence.  We therefore conducted a 
systematic review with a both pooled- and meta-analyses to investigate the incidence and 
factors influencing radial artery occlusion in the TRA setting. 
Methods 
 We searched MEDLINE and EMBASE on February 2015 using the broad search 
terms: ("radial occlusion" OR "radial artery occlusion") AND ("transradial" OR "radial 
catheterization" OR "radial artery catheterization" OR "radial artery catheterization" OR 
"radial artery catheterization"). The search results were reviewed by two independent 
investigators (CSK, MR) for studies that met the inclusion criteria and relevant reviews.  
Additional studies were retrieved by checking the bibliographies of included studies and 
relevant reviews. 
 We included primary studies that evaluated radial artery occlusion.  Studies were 
considered for detailed screening for inclusion if their abstract potentially met one of three 
criteria: 
1. Primary studies with participants and evaluation of radial occlusion. 
2. Any study which discusses RAO avoidance strategy  
3. Any study that evaluates pharmacology, access site management, sheath and catheter 
types, radial artery diameter and risk of radial occlusion. 
 We excluded studies that did not have results on radial artery occlusion but there was 
no restriction on the basis of types of interventions evaluated, language of study or single arm 
studies. We also excluded expert opinion and editorial reviews.  We included conference 
abstracts or presentations in the hope of minimizing publication bias. 
 Data were extracted from each study into preformatted tables generated in Microsoft 
Word.  The data collected were on the year, country, number of participants, age of 
participants, percentage of male participants, participant inclusion criteria, and type of 
interventions, follow up assessment, results and limitations.  With regards to limitations, we 
documented whether the study was retrospective in nature or was only available in 
conference abstract form as well as if it was single arm or there was a large loss to follow up.  
 Base on the availability of data we either synthesized the results using meta-analysis, 
quantitative pooling; graphically or by narrative synthesis.  Meta-analysis was performed by 
means of the random effects using RevMan 5.3 (Nordic Cochrane Centre, København, 
Denmark) in order to estimate pooled risk ratios (RRs). Statistical heterogeneity was assessed 
using I2 statistic, with values of 30-60% representing a moderate level of heterogeneity. (24) 
The method of pooling has been previously described. (25) In the final analysis, we excluded 
studies by the same research group over the same time period where there was the potential 
that the same participants were studied more than once.  Where there were similar study 
participants, we chose the study with the largest sample size or highest adverse outcome 
event rate. We also performed sensitivity analysis to detect the incidence of RAO according 
to the starting year of study, the completion year of the study and type of procedure 
performed i,e. diagnostic coronary angiography versus percutaneous coronary intervention. 
We pooled the timings of the study according to whether the studies were performed prior to 
2007, 2007-2008, 2009-2010 and 2011 onwards. 
Results 
 A total of 66 studies met the inclusion criteria. (18,20,25-88) The process of study 
selection is shown in Figure 1.  The details of the study design and participants are described 
in Table 1.  The included studies consisted of 9 retrospective cohort studies, 23 prospective 
cohort studies, 23 randomized studies, 2 matched/case-control studies and 7 cohort studies.  
There were a total of 31,345 participants with a mean age of 64 years and 70% male reported 
by 48 studies. The study size varied from 27 participants (56) to the largest cohort of 7,125. 
(86) 
 The use of interventions, follow up time, results and study limitations are shown in 
Table 2. Evaluation of RAO took place as short as 2-3 hours after procedure and as long as 
507 days after procedure. 25 of the studies were only available in abstract or presentation 
form. 33 studies reported RAO outcomes by using ultrasound assessment. (Figure 2 
supplementary table 1) 
 The incidence of RAO reported by the included studies ranged from <1% to 33% and 
we observed differences based on the timing of RAO evaluation (Figure 3). The studies 
which evaluated RAO within 24 hours, 24 studies with 10,938 participants reported a RAO 
incidence of 7.7% (SD =±4.23%, 95%CI ± 0.08%) (Figure 2A).  Among 8 studies that 
assessed for RAO between 24 hours to 1 week, the combined results with 1,377 participants 
was a RAO incidence of 9.5% (SD =±3.69%, 95%CI ±0.19%)(Figure 2B).  For RAO 
evaluated >1 week follow up, the combined results of 33 studies and 10,821 participants 
suggests that the RAO incidence was 5.56%(SD=±5.19, 95% ±CI ±0.1%) (Figure 2C).  In 
our sensitivity analysis to detect the temporal incidence of RAO over time we found a rising 
trend in incidence of RAO over time (P=0.02, for initiation year of study). (See 
Supplementary table 2). Additionally we also found that incidence of RAO during diagnostic 
coronary angiogram setting was much higher at 8.8% compared to the 4.5% in percutaneous 
coronary intervention (PCI) settings  (p<0.001).. 
 
 We found 14 trials which evaluated similar interventions that could be statistically 
pooled using meta-analysis (Figure 5).(29-31,35,37,42,43,45,46,48,69,76,83,85)  The only 
measure that significantly decreased RAO incidence was a higher dose of heparin RR 0.36 
(95%CI 0.17-0.76).(31,32,44,77) None of these studies reported increased bleeding risk with 
higher dose (5000IU) of heparin. Another intervention shown to reduce RAO was the 
duration of compression; with a 15 min compression associated with reduced risk of RAO 
compared to a 2-hour compression (RR 0.28 95% CI 0.05-1.50),(35,69) however Politi et al 
reported increased bleeding rates in patients subjected to shorter compression time.  
 We evaluated the incidence of RAO by size of catheter among 19 studies. (28, 29, 37, 
40,42,45-48,50,54-56,59,72,79,81,83,85) (Figure 4) We found a higher incidence of RAO 
with the increase in the size (outer diameter) of the catheter however the trend was not 
consistent amongst all studies particularly studies evaluating 8Fr size catheters, that consisted 
of a single study limited to 1 center. The incidence of RAO was 11% amongst 1297 
participants in studies evaluating 6Fr catheter dropping markedly to 2% in 2662 participants 
in studies using 5Fr catheter. 
 Several studies evaluated significant predictors of RAO.(18,19,30,32,35,41,44,49-
51,57,58,65,66,68,69,72,77,80,82,83,86)  Age was reported to a significant predictor of RAO 
in 3 studies (49,82,83) while gender was significant in 6 studies.(30,51,72,77,82,83)  Body 
weight was reported as a significant predictor in 3 studies.(18,68,80)  In terms of procedural 
variables, use of smaller introducer sheath has been shown to be predictive of lower RAO 
(75) and use of larger diameter of sheath (44,83,86) and duration of compression (64,86) was 
associated with higher occlusion rates.  Other predictors included baseline radial artery 
diameter (20,97-98), peripheral artery disease, (84) statin use, (44) procedural success, (49) 
serum creatinine, (51) and heparin use.(69) 
 Two studies evaluated the effectiveness of TR band compared to other TRA 
hemostatic devices in reducing radial occlusion.(63,70)  Pancholy et al conducted a study of 
500 patients and reported a statistically significant reduction in RAO with use of TR band 
compared to HemoBand (4.4% vs 11.2%). (63) Rathore et al compared Radistop and TR 
band in 790 patients and found a non-significant reduction in RAO with TR band compared 
to Radistop (5.6% vs 8.0%, p=0.273). (70) 
 Several studies reported the influence of medications on RAO. Abboud et al reported 
an abstract where they showed that administration of radial artery vasodilator cocktail 
administration before and after procedure significantly reduced RAO compared to just before 
procedure (0.5% vs 8%). (26) Ahmed et al conducted a study of participants with warfarin 
and reported higher incidences of RAO in the warfarin group compared to matched controls 
who received intra-procedural heparin. (27) Pancholy et al conducted a second study which 
compared administration of heparin after sheath insertion to no application of heparin unless 
post-procedure there was no radial patency and concluded that provisional use of heparin 
appears to be feasible and safe when patent hemostasis is maintained. (66) Plante et al 
compared bivalirudin and heparin and found no significant difference in RAO (3.5% 
bilvalirudin, 7.0% heparin) so they concluded that heparin should be preferred because its of 
low cost. (68) 
Discussion 
 TRA has become the default access site for cardiac catheterization in many countries 
across the world, and strategies to preserve the patency of the radial artery for future use are 
becoming an integral part of the catheterization procedure. Our analysis represents the first 
systematic review of such radial protection strategies, synthesizing evidence from over 66 
studies and 31,345 participants, to assess the incidence of and risk factors for RAO as well as 
to examine the efficacy of the measures used to prevent it. 
 Our analysis suggests that RAO is common, with incident rates for early RAO within 
24 hours 7.7% declining to 5.5% at 1- month. Clinically, absence of radial pulse is often 
described as occluded artery, however this can underestimate the true incidence of RAO. For 
example, in one study RAO incidence defined by absence of pulse were found to be 4.4% 
whereas absence of radial artery flow was found to be at 10.5%. (17) It is therefore 
recommended to use more objective method of assessment of RAO using radial flow using 
ultrasound. (96) In support of this, when studying the method of assessment of RAO, we 
observed that the incidence of RAO increased from 5.6% to 7.8% when ultrasound is used for 
detection of RAO.  Many baseline patient characteristics such as gender, Age, BMI and 
procedural variables such as artery to sheath ratio, heparin use and duration of compression 
have been reported to be associated with RAO, but there appears to be a lot of heterogeneity 
in the literature. The incidence of RAO varies according to the timing of assessment of radial 
artery patency post procedure. Acute RAO rates are higher acutely and decline with time.  In 
PROPHET study the acute incidence of RAO (12%) was almost halved by the passage of 28 
days (7%). (18) In accordance with these observations our analysis also suggests a decreased 
incidence of RAO over a period of 28 days from 7.7 % to 5.8 %. This decline in the incidence 
of radial artery occlusion with time can be explained by the spontaneous recanalization of 
radial artery. Recanalization occurs as the results of activation of primary fibrinolysis. The 
damaged endothelium facilitates this by releasing the tissue plasminogen activator and 
urokinase, thus allowing fibrinolysis to occur.  
 TRA also negatively affects the structure and function of radial artery culminating in 
non-occlusive injury. (13) Endothelial and vascular smooth muscle integrity play a central 
role in preserving the function of the arterial wall. Damaged and dysfunctional endothelium 
has been strongly attributed to development of vascular disease and atherosclerosis. (89) 
More recently changes in flow-mediated dilatation (FMD) has been used as a surrogate of 
endothelial dysfunction. (90) Flow mediated dilatation is (FMD) is an in vivo bioassay of 
NO-mediated endothelial function in which vascular endothelium releases NO as a 
vasodilatory response according to the changes in the vascular blood flow.  Yan et al recently 
demonstrated that average FMD post 5Fr TRA reduced significantly from 11.5% to 4.1% 
immediately after the procedure and dropped even further to 0.7% at 3 months. (91) This 
suggests that endothelial damage may actually persist longer than perceived.  Additionally, 
TRA also results in structural damage to the radial artery. Yonetsu et al studied the structural 
changes in radial artery from acute vascular trauma and found that 67% of radial arteries had 
intimal tears and 36% had medial dissections immediately after transradial PCI. (92) The 
combination of these structural and functional changes in arterial wall lead to significant 
arterial remodeling which may have important clinical implications. For instance, Sakai et al 
(93) studied patients undergoing repeated transradial interventions in the same arm and found 
that the rate of successful radial access decreases with successive procedures.   
 Acute artery occlusion is thought to be a thrombotic phenomenon on a background of 
chronic occlusive changes. Sheath insertion and instrumentation during trans-radial access 
causes endothelial damage exposing the thromobogenic connective tissue. In addition, blood 
stasis whilst achieving hemostasis provides the nidus for thrombus formation. Therefore, 
reducing endothelial damage by minimizing compression time and using small introducer 
sheath size along with patent hemostasis may help reducing the occlusion rates. Saito et al 
(94) studied the relationship between arterial blood flow and sheath size outer diameter and 
found that incidence of blood flow reduction is significantly low when radial artery inner 
diameter/cannulated sheath outer diameter is equal to or greater than 1.0 (artery/sheath 
diameter ratio>1). In this study, although the incidence of severe flow reduction was low 
without any ischemic sequel; the incidence of RAO was not reported. 
 We found that compression time of 15 minutes reduces RAO incidences significantly. 
(35,69) Although the results were very promising and statistically significant, both these 
studies were underpowered with less then 200 patients in total in both arms. (See Figure 3). 
Furthermore, Politi et al reported increase bleeding in patients subjected to shorter 
compression time in patent hemostasis settings. More recently, Duration of compression 
(>4hours versus <4 hours) was studied in a large randomized study by Dhrama et al. The 
found that duration of compression alone was strong predictor of RAO (OR 3.11 95% CI 
1.62-5.82) supporting the hypothesis of minimizing radial injury by reducing compression 
time. (88)  
 Use of low molecular weight heparin (LMWH) is another routine practice to prevent 
thrombus formation and occlusive injury to the vessel by the mechanism as discussed above. 
In very early studies investigating the role of anti-coagulants, Lefevre et al showed that the 
administration of heparin into the radial artery significantly reduced RAO. (95) Our results 
show that incidence of RAO increases by reducing the dose of intra-arterial heparin. (Figure 
5B) We found that heparin dose of 5000IU was very effective in preserving the patency of 
radial artery when compared with lower doses of 2000-3000IU (RR 0.36 95%CI 0.17-0.76). 
No increased risk of bleeding was reported in higher heparin arm.  We also observed a lower 
rate of RAO in PCI setting (4.5%) compared to diagnostic coronary angiogram setting 
(8.8%), which may relate to routine use of dual antiplatelet therapy and anti coagulants such 
as heparin or bivalirudin during the PCI procedure.  
 Other anti-coagulants such Bivalirudin and warfarin have also been studied as 
potential alternatives but did not show any significant benefit over LMWH, (67,68) therefore 
LMWH remains a preferred anti-coagulant due to lower costs. Our finding resonates with the 
recommendation made by SCAI trans radial working group who advocates the use of 5000IU 
heparin in all patients undergoing TRA. 
 Since the inception of TRA, there have been numerous advances in catheter and 
sheath designs to facilitate the procedure and minimize the insult to the artery. We studied 
radial sheath length and coating and found no influence on RAO outcome. In a randomized 
trial of 790 compared long (23cm) versus short (13cm) sheaths and hydrophilic-coated or 
uncoated introducer sheaths, the authors found that neither sheath length nor coating affects 
RAO. (71) However, it has been suggested that using small diameter guide catheter may 
reduce the injury to radial artery and resulting in less occlusion rates. (54) This led to various 
innovations in the catheter design to minimize the outer diameter including the development 
of sheathless guide catheters. Typically a 6Fr sheathless guide catheter has an outer diameter 
that is smaller than that of a 5Fr introducer sheath. We performed a pooled analysis to study 
the effect of various sizes (3Fr, 4Fr, 5Fr, 6Fr, 7Fr, 8Fr) on incidence of RAO (Figure 4). We 
observe that radial artery occlusion rates increase with increasing size of guide catheter 
systems used.  Although, the size of catheter seems to correlate with incidence of RAO in 
these studies, the overall results failed to show statistically significant benefit between 
smaller and larger catheter sizes (figure 5A). This may be because of under representation of 
smaller size catheter in these studies (Figure 4). Furthermore, a fair number of studies were 
single cohort studies undertaken without true randomization and may be subject to selection 
biases. In addition, there was no information available on the size (diameter) of radial artery 
in these studies which may also explain the inconsistencies of relation of RAO to catheter 
size. Radial artery diameter and sheath to artery size ratio have been associated with better 
RAO outcomes (22,98). Nevertheless, the individual studies have shown promising results in 
reducing radial injury supporting the hypothesis that small catheter size causes less radial 
artery trauma.  Larger randomized studies with pre-procedure ultrasonic assessment of radial 
artery diameter and sheath to artery ratio are required to show direct influence of catheter size 
on radial artery occlusion.  
 Patient’s baseline characteristics and procedural variables have been an area of 
interest to the researchers to predict occurrence of RAO (Table 3). Age, gender and BMI 
have been investigated to predict RAO at patient level whilst sheath to artery diameter, 
duration of compression (35,69) and anticoagulation (30,31) have been studied as possible 
predictors of RAO. In our analysis, no factors were found to have consistent predictability of 
RAO amongst all the studies; however, age, gender and body weight was most commonly 
reported predictors of RAO but there was no consistent direction of effect. For instance, 9 
studies evaluated gender and 6 found that it was significant in predicting the RAO outcomes. 
Similarly age was found to be a positive predictor on 3 out of the 5 studies reporting on RAO. 
A more streamlined reporting of these variables in the future trials may help to understand the 
influences on RAO. 
 We also analyzed the effect of various pharmacological interventions in reducing 
RAO.  In one study administration of vasodilator cocktail in addition of IV heparin before 
and after the procedure seems to have reduced the incidence of RAO. (26) Ahmed et al (27) 
also compared warfarin with LMWH to reduce RAO and concluded that warfarin was 
inferior to LMWH. In another prospective study, Zankl and colleagues (87) studied the 
efficacy of LMWH in treating the RAO post procedure and found that LMWH significantly 
improved the recanalization rates of radial artery. These studies suggest that use of additional 
anticoagulation post procedure may improve RAO outcome but these studies were conducted 
without true randomization.  Larger randomized studies are required to study the true effect 
of these medications in reducing radial artery occlusion. Finally, Bernat et al (31) used a non-
pharmacological novel intervention of compressing the ulnar artery post procedure to 
increase the flow in radial artery once occluded. They found significant lower rates of RAO 
post ulnar artery compression and concluded that by doing so flow thorough radial artery 
increases helping to reopen the artery post occlusion.  
 Our study has several limitations.  Many of the studies were included were single arm 
studies which we were only able to evaluate incidence of RAO.  We included conference 
abstracts to reduce publication bias but quality assessment from these studies poor because 
reporting of methods is brief.  While we found sufficient studies with similar interventions 
for statistical pooling many of the included studies were underpowered.   
 
Conclusion 
 To our knowledge, this is first systematic review and meta-analysis to date studying 
the incidence of radial artery occlusion and factors influencing RAO. We found incidence of 
RAO overall was 7.7% up to 24 hours and 5.8% at up to 30 days which is comparable with 
currently published literature.  There was variation in the timing of assessment of RAO in 
many studies and RAO rates decreased with time.  Shorter compression time in patent 
hemostasis setting and higher dose of heparin independently appears to reduce RAO. 
Relation of RAO to radial artery diameter needs to be evaluated in larger studies. Smaller 
sheath sizes have shown promising effects on reducing RAO in individual studies but these 
results needs to replicated in larger randomized trials to show the true effect of sheath size. 
Furthermore, adequately powered trials are needed to confirm if other interventions may 
reduce RAO. We studied the predictors and pharmacological treatments used to reduce RAO 
but found no consistency in the literature with better RAO outcomes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Flow diagram of study selection 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
926 results from search of MEDLINE and EMBASE using the following search terms on February 20, 2015: ((radial occlusion) OR (radial artery occlusion)) AND ((transradial) OR (radial catheterization) OR (radial artery catheterization) OR (radial artery catheterisation) OR (radial artery catheterisation)). 
115 potentially relevant articles. 
811 studies excluded because they did not meet inclusion criteria based on reviewing the title/abstract.  
51 studies excluded because they did not meet inclusion criteria after reviewing full text where available. 66 studies included in the review. 
Figure 2: Incidence of RAO by follow up time 
 Group No. of studies RAO events Total Mean% SD% 95%CI Margin RAO at 1 day 24 841 10938 7.69 4.23 0.08 RAO at 2-6 days 8 132 1377 9.59 3.69 0.19 RAO at 7+ days 33 602 10821 5.56 5.19 0.1   
Figure 2: supplementary table 1 
Exclusion of studies without ultrasonic assessment of RAO Group No. of studies RAO events Total Mean% SD% 95%CI Margin RAO at 1 day 12 360 5349 6.73 5.06 0.14 RAO at 2-6 days 7 126 1261 9.99 3.55 0.2 RAO at 7+ days 17 365 5721 6.22 6.47 0.17 Total  33 883 11193 7.89 7.79 0.14 
 
 
 
 
Figure 3: Incidence of RAO at shortest follow up time for each study 
 Group No. of studies RAO events Total Mean % SD% 95%CI Margin  Total 62* 1619 28747 5.63 6.50 0.08  *4 studies were not included because of duplicate analysis of the same cohort. 
 
Figure 4: Pooled Incidence of RAO by catheter size 
4A) Sheathless catheters 
 
 
Sheathless size No. Studies Events/Total % RAO 
3Fr 2 0/129 0 
4Fr 1 8/400 2 
6.5Fr 5 14/2020 0.7 
7.5Fr 2 7/146 4.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Pooled Incidence of RAO by catheter size 
4B) Conventional catheter system: 
 
 
Sheathed catheter No. Studies Events/Total % RAO 
4Fr 1 0/80 0 
5Fr 6 32/642 5 
6Fr 8 133/1151 11.6 
7Fr 2 15/77 19.5 
8Fr 1 2/18 11.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Meta-analysis of RAO by different interventions 
 A) Catheter size 
 B) High versus low dose heparin 
  C) 15 min versus 2 hours compression 
 
Table 1: Study design and participant characteristics 
Study ID Design; Country; Year No. of 
participants 
Age % male Participants inclusion criteria and setting 
Abboud 2013 Retrospective cohort study; USA; 
NA. 
400. NA. NA. Patients undergoing radial artery catheterization who received 
vasodilator cocktail before and both before and after catheterization. 
Ahmed 2012 Matched cohort study; USA; NA. 336. 72 years. 65%. Patients undergoing radial artery catheterization where group I had 
INR >2.0 and were on warfarin while group II were not on warfarin. 
Aminian 2014 Prospective cohort study; Belgium; 
May to Jun 2013. 
113. 63 years. 65%. Patients undergoing radial artery catheterization with Glidesheath 
Slender radial sheath. 
Ang 2013 Retrospective cohort study; 
Singapore; Nov 2008 to Jun 2013. 
832. NA. NA. Patients undergoing transradial coronary intervention sheathless 6.5 
Fr hydrophilic-coated guiding catheter compared to the standard 5 Fr 
guiding catheter.  
Aykan 2014 Randomized study; Turkey; NA. 459. 60 years. 77%. Patients undergoing radial artery catheterization who were 
randomized to 2,500 IU or 5,000 IU heparin. 
Bernat 2011 Randomized study; Czech Republic; 
NA.  
465. 61 years. 63%. Patients undergoing radial artery catheterization who were 
randomized to 2,000 IU or 5,000 IU heparin and ulnar artery 
compression. 
Buturak 2013 Prospective cohort study; Turkey; 
NA. 
409. 59 years. NA. Patients underwent transradial coronary procedure.  
Caussin 2010 Randomized study; France; Jan to Jun 
2006. 
351. 66 years. 67%. Patients undergoing transradial angiography who were randomized 
to long hydrophilic coated or a short sheath.  
Chiam 2011 Retrospective cohort study; 
Singapore; Nov 2008 to Sept 2010. 
269 patients, 
292 
procedures. 
57 years. 85% Patients undergoing transradial coronary intervention who received 
sheathless 6.5 Fr and 5Fr catheters.  
Chou 2014 Randomized study; China; NA. 100. NA. NA. Patients underwent first time transradial catheterization and were 
randomized to QuikClot or prolonged compression. 
Chugh 2013 Prospective cohort, India, 2006 to 
2011 
613. 57 years 63% Patients undergoing diagnostic or interventional cardiac 
catheterization. 
Cubero 2009 Randomized study; Spain; Dec 2007 
to Apr 2008. 
351. 65 years. 67%. Patients underwent transradial coronary angiography and were 
randomized to pneumatic compression guided by mean arterial 
pressure or standard procedure. 
Dahm 2002 Randomized study; Germany; Mar 
2000 to Oct 2001. 
171. 61 years. 59%. Patients with coronary lesions suitable for at least 5 Fr transradial 
angiography randomized to 5 Fr or 6 Fr PCI. 
Dangoisse 2012 Randomized study; Belgium; Jan 
2009 to Jun 2011. 
2,107. NA. NA. Transradial angiography using TR Band closure device. 
Dharma 2014 Randomized study; International; NA 1,706. 59 years. 68% Patients undergoing transradial catheterization. 
Edris 2014 Retrospective cohort study; USA; 
NA. 
115. NA. NA. Patients underwent transradial catheterization with TR band with 
standard protocol or rapid deflation. 
Feray 2009 Prospective cohort study; Turkey; 
NA. 
39. 55.6 
years. 
69%.  Patients underwent transradial catheterization with enoxaparin 
therapy. 
Gadkar 2011 Prospective cohort study; India; NA. 400. NA. NA. Patients underwent transradial angiography with 4 Fr sheathless 
catheter. 
Garg 2015 
 
Prospective cohort study; India; Jan 
2012 to Jun 2012. 
198. 58 years. 81%. Patients who underwent PCI. 
Hadi 2010 Cohort study; UK; NA. 161. NA. 77%. Patients who underwent PCI who received 6.5 Fr or 7.5 Fr sheathless 
catheter. 
Hahalis 2013 Randomized study; Greece; Jun 2010 
to Jan 2013. 
603. NA. 74.5%. 
 
Patients  with transradial catheterization were randomized to 2,500 
or 5,000 IU. 
Honda 2012 Prospective cohort study; Japan; NA. 
 
500. 70.7 
years. 
64%. Patients underwent transradial catheterization. 
Kindel 2008 Randomized study; Germany; NA. 200. NA. NA. Patients underwent transradial catheterization who were randomized 
to coated/5F, control/5F, coated/6F and control 6F. 
Kinoshita 2011 Prospective cohort study; Japan; Aug 
2009 to Aug 2010. 
325. NA. NA. Patients who  underwent PCI with 6.5 Fr sheathless guides and 6.5 
Fr guides. 
Kwan 2012 
 
Prospective cohort study; USA; Dec 
2010 to Feb 2011. 
116. 66 years. 
 
74. Patients underwent transradial intervention with 7 Fr sheathless 
guiding catheter. 
Lala 2014 Retrospective cohort study; USA; Jan 
2011 to Dec 2011. 
106. 71 years. 
 
NA. Patients underwent transradial PCI with 5, 6 and 7 Fr catheter. 
Lee 2014 Prospective cohort study; Taiwan; Jan 
2010 to Jun 2012. 
133. 66 years. 75% Patients underwent transradial intervention. 
Levin 2014 Prospective cohort study; Israel; NA. 43. NA. NA. Patients underwent transradial intervention with 7 Fr sheath. 
Lisowska 2015 Prospective cohort study; Poland; 
2010 to 2012. 
220. 64 years. 
 
76%.  
 
Patients with acute coronary syndrome who underwent coronary 
angiography and angioplasty via radial access. 
Lopes de Sá 
2013 
Randomized study; Brazil; Nov 2010 
to Jul 2011. 
228. 60 years. 58%. Patients underwent transradial catheterization and were randomized 
to brand new introducers or reprocessed introducers. 
Mamas 2010 Prospective single arm study; UK; Jul 
2008 Nov 2008. 
100. 60 years. 75%. Patient underwent PCI via transradial angiography with 6.5 Fr 
sheathes guide catheter. 
Markovic 2015 Prospective cohort study; Germany; 
NA. 
369. 68 years. 85% 
 
Patients underwent transradial catheterization with 5 Fr or 6 Fr 
sheath. 
Matsumoto  
2011 
Retrospective cohort study; Japan; 
Jun to Sept 2010.  
100. NA. NA. Patient underwent PCI via  transradial angiography  using 7.5 Fr 
sheathless guide catheter. 
Mizuno 2010 Retrospective cohort study; Japan; 
Dec 2008 to Sept 2009. 
27. 73 years. 59%. Patient underwent PCI using virtual 3 Fr guiding catheter. 
Moarof 2014 Prospective observational study; 
Switzerland; Jan 2010 to Oct 2013. 
395. 66  years. 88% Patients underwent transradial coronary angiography or PCI. 
Monsegu 2012 Prospective cohort study; 574 . NA. NA. Patients underwent cardiac catheterization with 5 Fr or 6 Fr 
International; NA. introducer sheath and catheter. 
Nakamura  
2011 
Cohort study; Japan; Jun 2005 to Dec 
2009. 
892. NA. NA. Patients underwent transradial intervention of 6.5 Fr sheathless guide 
catheter. 
Nagai 1999 Retrospective cohort study; Japan; 
Sept 1996 to Dec 1997. 
162. 64 years. 64%. Patients undergoing transradial coronary angiography and 
angioplasty. 
Ozdemir 2013 Randomized study; Turkey; Apr to 
Oct 2012. 
103. NA. NA. Patients underwent coronary angiography with transradial approach 
and were randomized to enoxaparin or no enoxaparin therapy. 
Pancholy 2008 Randomized study; USA; NA. 463. 65 years. 50%. Patients underwent transradial catheterization who were randomized 
to conventional pressure application or pressure application 
confirming radial artery patency using Barbeau's test in the 
PROPHET study. 
Pancholy 2009a Randomized study; USA; Nov 2007 
to Dec 2008. 
500. 64 years. 61%. Patients underwent transradial diagnostic coronary angiography and 
were randomized to intravenous or intra-arterial heparin. 
Pancholy 2009b Randomized study; USA; Nov 2007 
to Dec 2008. 
500. NA. NA. Patients underwent transradial catheterization who were randomized 
to HemoBand or inflatable TR band. 
Pancholy 2012a Retrospective cohort study; USA; 
NA. 
400. 64 years. 63%. Patients underwent transradial catheterization who had 2 or 6 hours 
of hemostatic compression. 
Pancholy 2012b Randomized study; USA; NA. 412. 64 years. 71%. Patients underwent transradial catheterization and were randomized 
to Seldinger and modified Seldinger technique. 
Pancholy 2012c Randomized study; USA; NA. 400. 64 years. 63%. Patients underwent transradial catheterization and were randomized 
to heparin or no heparin in the PHAROAH study. 
Pancholy 2014 Case-control study; USA; Jan 2009 to 
Dec 2011. 
336. 72 years. 65%. Patients underwent transradial catheterization who had therapeutic 
warfarin matched to controls. 
Plante 2010 Cohort study; Canada; NA. 400. 60 years. 76% Patients underwent transradial catheterization and received heparin 
or bivalirudin. 
Politi 2011 Randomized study, Italy; Nov 2009 
to Jan 2010. 
120. 62 years. 73%. Patients underwent transradial catheterization and were randomized 
to QuikClot, short compression or conventional compression. 
Rathore 2010a Randomized study; UK; Nov 2006 to 
Jan 2008. 
794. 63 years. 74%. Patients underwent transradial catheterization and were randomized 
to TR band or Radistop compression. 
Rathore 2010b Randomized study; UK; Nov 2006 to 
Jan 2008. 
790. 63 years. 74%. Patients underwent transradial catheterization and were randomized 
to long, short, coated and uncoated sheaths. 
Ruhnau 2013 Cohort study; Germany; NA. 415. 66 years. 66%. Transradial intervention using 6 Fr sheath. 
Sanmartin 2007 Prospective cohort study; Spain; NA. 275. 64 years. 79%. Patients underwent transradial catheterization. 
Schiano 2010 Randomized study; France; Sept 2007 
to Mar 2008.  
162. 63 years. 65%. Patients underwent radial catheterization.  
Shantha 2014 Prospective cohort study; USA; Jan 
2009 to Dec 2013. 
1,251. 65 years. 63%. Patients underwent 6 Fr PCI. 
Spaulding 1996 Prospective cohort study; France; 415. 58 years. 85%. Patients underwent transradial catheterization and assessed for 
 Mar 1994 to Jun 1995. procedural success and vascular complications. 
Sreevatsa 2014 Cohort study; India; NA. 176. 56 years. 85%. Patients underwent transradial PCI who either had patent hemostasis 
or conventional hemostasis. 
Stella 1997 Prospective cohort study; 
Netherlands; Aug 1992 to Oct 1995. 
563. 60 years. 76%. Patients with transradial PCI 
Takeshita 2014 Randomized study; International; 
NA. 
160. 68 years. 79%. Patients undergoing transradial catheterization who were randomized 
to 4 Fr or 6 Fr guiding catheter. 
Tonomura 2014 Prospective cohort study; Japan; Jul 
2010 to Dec 2012.  
132. 70 years. 71%. Patient undergoing elective PCI via transradial approach using 
virtual 3Fr sheathless guide system. 
Tuncez 2013 Prospective cohort study; Turkey; 
Aug 2011 to Mar 2012. 
106. 58 years. 43%. Patients underwent tranradial coronary angiography and PCI. 
Uhlemann 2012a Prospective cohort study; Germany; 
Nov 2010 to Jan 2011. 
33. 72 years. 67%. Patients with transradial cardiac catheterization who had oral 
anticoagulation. 
Uhlemann 2012b Prospective cohort study; Germany; 
Nov 2009 to Aug 2010. 
455. 65 years. 62%. Patients with transradial cardiac catheterization who had 5 Fr and 6 
Fr sheath. 
Wong 2012 Randomized study; Singapore; NA. 217. 58 years. NA. Patients undergoing PCI via 6 Fr trans radial approach. 
Wu 2000 Randomized study; USA; NA. 40. NA. NA. Trans radial coronary intervention. 
Zhou 2007 Cohort study; China; Aug 2002 to 
Feb 2006. 
7,125. 64 years. 71% Patients with transradial PCI. 
Zankl 2010 Cohort study; Germany; 2007 and 
Apr 2009 . 
488. 64 years. 65%. Patients undergoing trans radial catheterization.  
Table 2: Results of studies and quality assessment 
Study ID Use of any interventions RAO outcomes and 
timing of evaluation 
Results Study limitations 
Abboud 2013 Administration of vasodilator 
cocktail with 2.5 mg verapamil and 
200 µg nitroglycerin before and 
both before and after 
catheterization. 
Incidence of RAO. 
Follow up in clinic but 
unclear timing. 
Incidence of RAO in both groups: 17/400. 
RAO with cocktail before and after: 1/200. 
RAO with cocktail before: 16/200. 
Abstract only, retrospective and 
lack of randomization. 
Ahmed 2012 Warfarin vs no warfarin groups. Incidence of RAO with 
plethysmography at 24 
hours and 30 days. 
Incidence early RAO in both groups: 41/336. 
Early RAO with warfarin: 16/86 (18.6%). 
Early RAO without warfarin: 25/260 (9.6%). 
Incidence chronic RAO in both groups: 26/336. 
Chronic RAO with warfarin: 12/86 (13.9%). 
Chronic RAO without warfarin: 14/260 (5.2%). 
Abstract only, and lack of 
randomization. 
Aminian 2014 All patients had Glidesheath 
Slender radial sheath.(OD=5 Fr) 
Incidence of RAO at 1 
month follow up. 
Incidence of RAO: 1/113. None. 
Ang 2013 6.5 Fr hydrophilic-coated 
sheathless guiding catheter (OD=4 
Fr)compared to the standard 5 Fr 
guiding catheter.  
RAO in each group (no 
timing specified) 
Incidence of RAO in both groups: 2/832. 
RAO with 5Fr group: 1/146. 
RAO with 6.5Fr group: 1/686. 
Abstract only, retrospective and 
lack of randomization. 
Aykan 2014 2,500 IU versus to 5,000 IU 
heparin. 
Radial artery patency 
evaluated 1 month after 
angiography with 
Doppler US. 
Incidence of RAO in both groups: 15/459. 
RAO with 2,500 IU heparin: 12/217. 
RAO with 5,000 IU heparin: 3/242. 
Presentation slides only. 
Bernat 2011 2,000 IU versus 5,000 IU heparin. 
Ulnar artery compression  
RAO with duplex US 
after 3-4 hours. 
Incidence of early RAO in both groups: 20/465. 
Early RAO with 2,000 IU heparin: 13/222 (5.9%).  
Early RAO with 5,000 IU heparin: 7/243 (2.9%). 
Incidence of final RAO in both groups: 11/465. 
Final RAO with 2,000 IU heparin: 9/222 (4.1%) 
Final RAO with 5,000 IU heparin: 2/243 (0.8%) 
None. 
Buturak 2013 No intervention. Doppler US at 6-15 
months. 
Late term RAO incidence: 67/342 (16.4%). 
RAO with age: 55.9 years vs 59.1 years. 
RAO with hypertension: 9.8% vs 23.0%. 
Abstract only. 
Caussin 2010 Long hydrophilic-coated versus a 
short sheath. 
RAO a day after 
procedure with US 
Doppler. 
RAO incidence: 10/351. 
RAO with long sheath: 5/177 (3.5%). 
RAO with short sheath: 5/174 (3.5%).  
Not primary outcome of trial. 
Chiam 2011 6.5Fr sheathless versus 5Fr guiding 
catheters.  
RAO in hospital. RAO incidence: 2/292. 
RAO with sheathless group: 1/146 (0.7%) 
Retrospective, unclear outcome 
ascertainment.   
 RAO with 5Fr group: 1/146 (0.7%) 
Chou 2014 Short compression with QuikClot 
(15 minutes) and a conventional 
prolonged compression (2 hours) 
Early RAO <24hrs and 
Late RAO 1-2 months 
with color Doppler. 
Early RAO incidence: 1/100. 
Early RAO short compression: 0/50 (0%). 
Early RAO conventional compression: 5/50 (10%). 
Late RAO incidence: 3/100. 
Late RAO short compression: 0/50 (0%). 
Late RAO conventional compression: 3/50 (6%). 
Abstract only. 
Chugh 2013 Assessment of radial artery 
diameter using ultrasound 
Early RAO after the 
procedure using 
ultrasound Doppler. 
Late RAO at 4 weeks 
Early RAO incidence: 3/613 
Late RAO incidence: 1/613 
Single cohort study with limited 
follow up in last 10 months 
only. 
Cubero 2009 Compression guided by mean 
arterial pressure or standard 
compression by pneumatic air 
device. 
24-72 hrs using inverse 
Allen test and 
bidirectional Doppler.  
 
Incidence of RAO: 23/351. 
RAO in mean arterial pressure group: 2/176. 
RAO in standard compression group: 21/175. 
Single-blinded study. 
 
Dahm 2002 5Fr versus 6 Fr. Radial artery 
assessment using 
duplex at unclear 
timing. 
Incidence of RAO: 6/171. 
5 Fr arm: 1/87 (1.1%) 
6 Fr arm: 5/84 (5.9%) 
Four of the five 6Fr Patient had artery: catheter ratio 
<1. 
Unclear timing of RAO. 
Dangoisse 2012 Low (13cc) volume of air versus 
Ultra low (10cc) volume of air in 
TR Band. 
RAO assessment at 
24hours using pulse 
oximetry. 
RAO at 24 hours: 169/2107 (8%). Abstract study only. 
Dharma 2014 Intra-arterial administration of 
nitroglycerin (500mcg) versus 
placebo post procedure. 
RAO assessment at 24 
hours using ultrasound 
duplex 
Incidence of RAO: 170/1706 (9.9%) 
RAO incidence in nitroglycerin arm: 70/853(8.3%) 
RAO incidence in placebo arm: 100/853(11.7%) 
 
None. 
Edris 2014 Standard technique versus rapid 
deflation technique. 
RAO at 24 hrs using a 
reverse-Barbeau test.  
 
Incidence of RAO: 11/115. 
RAO in standard group: 9/56 (16%). 
RAO in rapid deflation group: 2/59 (3.4%).  
Abstract only, retrospective, 
non-randomized.  
Feray 2009 All patients received 60 mg 
enoxaparin through the radial 
sheath. 
RAO at discharge and 
5.5 days follow-up 
with Doppler exam. 
Incidence of RAO: 2/40 (4%). Single arm study. 
Gadkar 2011 4 Fr sheathless. RAO at unclear timing 
of evaluation. 
Incidence of RAO 8/400 (2%). 
 
Non-randomized. 
Garg 2015 
 
None. US Doppler 1 day 
before, 1 day after, and 
3 months after the 
Incidence of RAO: 30/198 (15.2%). None. 
procedure. 
Hadi 2010 6.5 Fr versus 7.5 Fr sheathless 
catheter. 
RAO at one month. Incidence of RAO: 6/161. 
RAO in 6.5 Fr sheathless: 5/131 (3.8%). 
RAO in 7.5 Fr sheathless: 1/30 (3.3%). 
Abstract only, significant loss to 
follow up 35%. 
Hahalis 2013 2,500 versus 5,000 IU of heparin.  
 
Median follow-up of 8 
days with Doppler US. 
 
Incidence of RAO: 61/603. 
RAO in 2,500 IU arm: 36/302 (12.0%) 
RAO in 5,000 IU arm: 25/301 (8.4%) 
Abstract only. Significant loss 
to follow up 52%. 
Honda 2012 None. US at 24 hrs. Incidence of RAO: 52/500. None. 
Kindel 2008 Hydrophilic-coated versus non-
coated sheaths and 5F versus 6F 
catheters. 
RAO at one month 
with US Doppler. 
Incidence of total RAO: 15/200. 
Incidence of early occlusion: 12/200. 
Coated/5F: 3/50. Control/5F: 4/50. Coated/6F: 4/50. 
Control/6F: 1/50. 
Incidence of late occlusion: 3/200. 
Coated/5F: 1/50. Control/5F: 0/50. Coated/6F: 1/50. 
Control/6F: 1/50. 
None. 
Kinoshita 2011 6.5 Fr sheathless guides versus 6F 
guides. 
RAO at 3 months. Incidence of RAO: 6/333. 
RAO in 6.5 Fr sheathless guide group: 0/211 (0%) 
RAO in 6F guide group 6/122 (5%).  
Abstract only.  
Kwan 2012 
 
7F sheathless guiding catheter. 
 
7 days and 30 days 
RAO plethysmography 
assessment. 
Incidence of RAO: 9/116. 
RAO 7 days 6/116 (5%) 
RAO 30 days: 3/116 (2.5%) 
None.  
Lala 2014 5Fr, 6Fr and 7Fr guiding catheter. RAO at 1 day and 30 
days. 
Incidence of RAO: 12/106. 
RAO with 5Fr: 1/44 (2%) 
RAO with 6Fr: 4/28 (14%) 
RAO with 7Fr: 7/34 (20%)  
Abstract only, retrospective, 
non-randomized study. 
Lee 2014 Sheathless standard guiding 
catheters for complex coronary 
interventions and carotid artery 
stenting. 
RAO at 1 year. Incidence of RAO: 6/133. 
RAO for coronary intervention: 3/105 (2.86%). 
RAO for carotid artery intervention: 3/28 (10.71%). 
None. 
Levin 2014 7 Fr sheath catheter. 507 days by US and 
Barbeau test.  
 
Incidence of RAO: 8/43 (19%). Abstract only. 
Lisowska 2015 None.  US at 48-72 hrs and 6-
12 months. 
Periprocedural RAO: 33/220 (15%). 
Long term RAO: 28/220 (13%). 
None. 
Lopes de Sá 
2013 
 
Brand new introducers versus 
reprocessed introducers. 
RAO was evaluated at 
24 hrs (early) and 30 
days (late) with the 
reverse Barbeau test.  
Incidence of early RAO: 24/228. 
Incidence of late RAO: 17/186. 
RAO in new introducers: early 10/100 (10%), late 
6/80 (7.5%). 
Loss to follow up 18.4%.  
 RAO in reprocessed introducers: early 14/128 
(10.9%), late 11/106 (10.4%).  
Mamas 2010 TRA PCI using 6.5 Fr Sheathless 
guide catheter.  
RAO at 60 days using 
Doppler US. 
RAO at 60 days: 2/100 (2%). Single arm study. 
Markovic 2015 None. Doppler US at 24 hrs. Incidence of RAO: 14/369. 
RAO with 5Fr: 1/45 (2%). 
RAO with 6Fr: 13/324 (4%). 
None. 
Matsumoto  
2011 
PCI via TRA using 7.5 Fr 
sheathless guide catheter. 
RAO assessment at 
unclear timing and 
method 
Incidence of RAO: 0%. Abstract study with limited 
information. Single arm study. 
Mizuno 2010 PCI using 3 Fr virtual sheathless 
guiding catheter. 
RAO assessment at 
unclear timing using 
Allen’s test and US 
Doppler 
Incidence of RAO in TRA group: 0/18 (0%). Single arm study with unclear 
timing of assessment of RAO. 
Moarof 2014 None. Color duplex US up to 
34 months. 
Incidence of long term RAO: 7/385. Abstract only.  
Monsegu 2012 None. Color Doppler with 
and without ulnar 
compression at 24 hrs. 
Incidence of RAO 22/574 (3.8%). Abstract only. 
Nakamura  
2011 
6.5 French sheathless guide 
catheter. 
6-9 months RAO with 
Doppler. 
Incidence of RAO: 6/892 (0.67%).  
 
Abstract only, loss to follow up 
23%. 
Nagai 1999 US assessment of radial artery post 
procedure. 
Radial artery 
assessment at early (1-
8 days) and late (37-
182 days). 
Early undetectable flow confirmed on US 15/162 
(9%). 
Late RAO= 6/162 (3%). 
Retrospective single arm study. 
Ozdemir 2013 Subcutaneous enoxaparin (60 
mg/day) after 4 hours of sheath 
removing and each after 3 days 
versus no enoxaparin.  
RAO at 7 days using 
US Doppler and pulse 
oximetry. 
Incidence of RAO: 14/103. 
RAO in enoxaparin group: 1/51 (2%). 
RAO in control group: 13/52 (25%). 
Abstract only. 
Pancholy 2008 Conventional pressure application 
for hemostasis versus pressure 
application confirming radial artery 
patency using Barbeau’s test.  
24 hrs and 30 days 
using 
plethysmography. 
 
Incidence of RAO at 24 hrs: 38/436. 
Incidence of RAO at 30 days: 20/436. 
RAO in conventional group at 24 hrs: 27/219 (12%). 
RAO in conventional group at 30 days:16/219 (7%). 
RAO in Barbeau's test group at 24 hrs: 11/217 (5%). 
RAO in Barbeau's test group at 30 days: 4/217 (2%). 
None. 
Pancholy 2009a Intravenous versus intra-arterial 
heparin. 
RAO with 
plethysmography at 24 
hours and 30 days. 
Incidence of early RAO: 29/500. 
Incidence of chronic RAO: 18/500. 
Early RAO in intravenous group: 14/250 (5.6%). 
None. 
Chronic RAO in intravenous group: 8/250 (3.2%). 
Early RAO in intra-arterial group: 15/250 (6%). 
Chronic RAO in intra-arterial group: 10/250 (4%). 
Pancholy 2009b HemoBand versus TR Band for 
haemostasis. 
RAO at 24 hrs and 30 
days with Barbeau’s 
test. 
 
Incidence of RAO at 24 hrs: 39/500. 
Incidence of RAO at 30 days: 26/500. 
RAO at 24 hrs with Hemoband: 28/250 (11.2%). 
RAO at 30 days with Hemoband: 18/250 (7.2%). 
RAO at 24 hrs with TR Band: 11/250 (4.4%). 
RAO at 30 days with TR Band: 8/250 (3.2%). 
None. 
Pancholy 2012a Duration of compression 2 hrs 
versus 6 hrs. 
RAO at 24 hrs and 30 
days. 
Incidence of early RAO: 35/400. 
Incidence of chronic RAO: 24/400. 
Early RAO in 6 hrs group: 24/200 (12%). 
Chronic RAO in 6 hrs group: 17/200 (8.5%). 
Early RAO in 2 hrs group: 11/200 (5.5%). 
Chronic RAO in 2 hrs group: 7/200 (3.5%). 
Retrospective cohort study.  
Pancholy 2012b Seldinger technique versus 
modified Seldinger technique.  
RAO at 24 hrs and 30 
days. 
 
Incidence of early RAO: 33/412. 
Early RAO with Seldinger: 17/210 (8%). 
Early RAO with modified Seldinger: 16/202 (7.9%). 
Incidence of late RAO: 17/412. 
Late RAO with Seldinger: 9/210 (4.3%). 
Late RAO with modified Seldinger: 8/202 (3.9%). 
None. 
Pancholy 2012c A Priori heparin versus provisional 
heparin. 
Plethysmograph for 
RAO at 24 hrs and 30 
days. 
Incidence of early RAO: 29/400. 
Incidence of late RAO: 19/400. 
Early RAO in a Priori: 15/200 (7.5%). 
Early RAO in provisional: 14/200 (7%). 
Late RAO in a Priori: 9/200 (4.5%). 
Late RAO in provisional: 10/200 (5%). 
None. 
Pancholy 2014 Warfarin versus intra-arterial 
heparin. 
Plethysmograph for 
RAO at 24 hrs and 30 
days.  
Incidence of early RAO: 40/336. 
Incidence of late RAO: 25/336. 
Early RAO in warfarin group: 16/86 (18.6%). 
Early RAO in heparin group: 24/250 (9.6%). 
Late RAO in warfarin group: 12/86 (13.9%). 
Late RAO in heparin group: 13/250 (5.2%). 
Retrospective study. 
Plante 2010 Heparin versus bivaluridin. RAO at 4-8 weeks  
echography-Doppler 
and reverse Allen’s test 
with pulse oximetry. 
Incidence of RAO 21/400 (5.3%). 
RAO with heparin 14/200 (7.0%). 
RAO with bivalirudin 7/200 (3.5%). 
Non randomized study 
Politi 2011 Short compression with the Radial artery patency Incidence of RAO: 6/120. None. 
QuikClot, short compression or 
conventional prolonged 
compression. 
was assessed using the 
Barbeau’s test 12 at 24 
hrs. 
RAO with QuikClot: 0/50 (0%). 
RAO with short compression: 1/20 (5%). 
RAO with prolonged compression: 5/50 (10%). 
Rathore 2010a Radistop device versus TR band 
hemostasis. 
RAO at discharge and 
follow up after 4-6 
months with 
plethysmography and 
oximetry 
Incidence of RAO at discharge: 73/790 (9.2%). 
Incidence of RAO at follow up: 43/790 (6.8%). 
RAO at discharge with Radistop: 38/395 (9.6%). 
RAO at discharge with TR band: 35/395 (8.9%). 
RAO at follow up with Radistop: 25/395 (8%). 
RAO at follow up with TR band: 18/395 (5.6%). 
None. 
Rathore 2010b Long versus short sheet and  
hydrophilic coated versus non 
coated sheet. 
RAO at discharge and 
follow up. 
Incidence of RAO at discharge: 73/790 (9.5%) 
Incidence of RAO at follow up: 43/625 (6.9%) 
RAO with long sheet: discharge 31/396, follow-up 
27/325.  
RAO with short sheet: discharge 42/394, follow-up 
16/302. 
RAO with coated: discharge 35/397, follow-up 
24/316. 
RAO with uncoated: discharge 28/393, follow-up 
19/311. 
None. 
Ruhnau 2013 TRA using 6Fr sheath. RAO at 4-68 weeks 
using US duplex. 
Incidence of RAO:  15/418 (3.6%) 
Female are at higher risk of RAO (n=10 vs n=5) 
 
Abstract study only. 
Sanmartin 2007 None. RAO at 7 days with 
pulse oximeter and 
plethysmograph. 
Absent pulsation: 12/279 (4.4%). 
Absent radial flow: 29/279 (10.5%). 
None. 
Schiano 2010 5000IU heparin versus weight 
adjusted (50units/Kg) heparin. 
RAO assessment at 24 
hours using US 
Doppler. 
Incidence of RAO: 0/162 (0%). 
Incidence of RAO in control group 0/79 (0%) 
Incidence of RAO with weight adjusted heparin 
group 0/83 (0%). 
Radial compression time was higher in the standard 
protocol group (235.5 min, vs. 204.5 min, p<10-5). 
 
None. 
Shantha 2014 Introducer sheath or without 
introducer sheath. 
Radial artery patency 
was assessed using 
reverse Barbeau’s test 
and RAO was 
confirmed by US. 
Lower RAO with introducer sheath: 
Propensity matched odds of RAO pre-discharge: OR 
0.20 (0.13-0.32). 
Propensity matched odds of RAO at 24 hrs: OR 0.13 
(0.07-0.25). 
Abstract only. Unclear variables 
in propensity matching. 
Propensity matched odds of RAO at 30 days: OR 
0.18 (0.10-0.40). 
Spaulding 1996 No heparin, heparin 2000-3000 
units and heparin 5000 units. 
RAO assessment post-
procedure and at 2 
month follow-up using 
echo-Doppler 
measurements 
Incidence of RAO: 73/415. 
No heparin group: 35/49 (71%).  
Heparin 2,000-3,000 units: 29/119 (24%). 
Heparin 5000 units: 9/210 (4.3%). 
Non randomized study.  59% of 
participants were excluded. 
Sreevatsa 2014 Patent hemostasis versus occluded 
hemostasis. 
Barbeau’s test and 
Doppler at 24 hrs. 
Incidence of RAO: 23/176 (13.1%). 
RAO with patent hemostasis: 6/87. 
RAO with occluded hemostasis: 17/89. 
Abstract only. 
Stella 1997 None. RAO assessment at 
discharge and one 
month via palpation 
and Allen’s test 
Incidence of early RAO: 30/563 (5.3%) 
Incidence of late RAO (30days): 16/563 (2.8%) 
None 
Takeshita 2014 4Fr versus 6Fr guiding catheter. RAO on reverse Allen 
test. 
Incidence of RAO: 3/160. 
RAO in 4Fr group: 0/80. 
RAO in 6Fr group: 3/80. 
None. 
Tonomura 2014 3 Fr sheath less guide system 2-3 days post 
procedure using 
reverse Allen’s test 
Incidence of RAO: 0/111 (0%). Single cohort; follow up not 
done on all patients. 
Tuncez 2013 None. RAO at 24 hours with 
US Doppler. 
Incidence of RAO: 10/106.  
Predictor of RAO: low weight (p=0.01). 
None.  
Uhlemann 2012a All patients had oral 
anticoagulation. 
RAO at discharge on 
Duplex US. 
Incidence of RAO: 11/33 (33%). None. 
Uhlemann 2012b 5F sheath and 6F sheath. RAO at discharge on 
Duplex US. 
Incidence of RAO: 113/455. 
RAO with 5F sheath: 21/152 (13.7%). 
RAO with 6F sheath: 92/303 (30.5%). 
Non-randomized study. 
Wong 2012 Intravenous enoxaparin vs intra-
arterial UFH 
RAO assessment at 6 
weeks 
Incidence of RAO 10/217. 
Incidence of RAO in enoxaparin group: 5/106 
(4.71%). 
Incidence of RAO in control group: 5/111 (4.50%). 
Abstract study. 
Wu 2000 8 Fr and 6 Fr sheath. RAO assessment at one 
year. 
Incidence of RAO in 8Fr arm: 2/18 (11%). 
Incidence of RAO in 6Fr arm: 3/16 (19%). 
Small study; limited follow up 
in 8Fr arm. 
Zhou 2007 None. RAO unclear timing of 
evaluation. 
Incidence of RAO: 68/7215 (1%). Single arm study. 
Zankl 2010 
 
RAO post transradial angiography 
treated with LMWH for four 
weeks. 
RAO assessed at 24 
hours. 
Incidence of RAO at 24 hours: 51/488 (10.5%). 
RAO at 4 week in patients treated with LMWH: 4/30 
(13.3%). 
None.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RAO at 4 weeks in patients not treated with LMWH: 
17/21 (81%). 
Supplementary table 2: Sensitivity analysis according to the timing of the studies and setting of procedure 
 
a) Analysis by timing of studies 
 
Starting year of study Studies Events/Total % RAO 
<2006 9 284/11,172 2.5 
2007-2008 8 119/2,743 4.3 
2009-2010 14 482/5,280 9.1 
2011+ 5 67/626 10.7 (p=0.02) 
Completion year of study Studies Events/Total % RAO 
<2006 6 202/8,877 2.3 
2007-2008 5 137/1,903 7.2 
2009-2010 8 184/2,698 6.8 
2011+ 17 429/6,343 6.8 (p=0.38) 
 
b) Analysis by setting of procedure: 
 
Group Studies Events/Total %RAO 
Percutaneous coronary 
intervention (PCI) 
21 206/4533 4.5  
Coronary angiograms (CA) 13 364/4147 8.8  
PCI + CA 18 451/6631 6.8 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Predictors of radial artery occlusion 
Study ID Results 
Aykan 2014 Predictors of RAO: male (p=0.008), age (p=0.950), body mass index (p=0.838), hypertension (p=0.035), dyslipidemia (p=0.034), diabetes (p=0.963), 
smoking (p=0.252), glucose (p=0.941), HDL (p=0.094), LDL (p=0.309), triglycerides (p=0.237), creatinine (p=0.747), GFR (p=0.179), fluoroscopy time 
(p=0.893), procedure time (p=0.659), sheath removal time (p=0.001), heparin group (p=0.010).  
Buturak 2013 Predictor of RAO: sheath-to-artery ratio >1 (p<0.001). 
Chou 2014 Predictor of RAO: duration of occlusive compression OR 12.7, p=0.001. 
Cubero 2009 Univariate predictors of RAO: ex-or active smoker p=0.04 , absence antiaggregant p=0.04 
Multivariate predictors of RAO: presence of RA flow after procedures HR 0.06 (0.01-0.2), total haematoma HR 3.7 (1.2-11.0), standard pneumatic 
compression HR 18.8 (3.8-92.2).  
Dharma 2014 Multivariate predictors of RAO: Duration of hemostasis >4hours OR 3.11(1.66-5.82), Intra-arterial nitroglycerin use OR 0.62(0.44-0.87). 
Garg 2015 Predictors of RAO: female gender OR 0.75 (0.19-2.93), diabetes OR 0.74 (0.22-2.51), BMI 0.91 (0.83-1.56), radial artery size ≤2.5mm OR 40.54 (9.91-
165.81), radial artery peak systolic velocity OR 0.94 (0.90-1.00), radial artery diameter to sheath ratio <1 OR 0.89 (0.16-5.06). 
Honda 2012 Significant predictors of occlusion: outer diameter of sheath OR 5.24 (1.21-22.8), statin medications OR 0.501 (0.255-0.985).  
Lee 2014 Significant predictors of RAO: age (p=0.032), procedure success (p=0.032). 
Levin 2014 Predictors of RAO: reduced body weight (p=0.031). 
Lisowska 2015 Significant predictors of RAO: men (p=0.025), creatinine (p=0.04). 
Moarof 2014 Predictors of RAO: sheath size OR 0.67 (0.13-3.50), compression time OR 0.87 (0.45-1.67), gender OR 0.59 (0.70-5.00), heparin dose OR 0.98 (0.85-
1.11), procedure time OR 0.99 (0.97-1.01). 
Monsegu 2012 Significant predictors of RAO: no-use of profile sheath (p<0.001), no pulse after TR Band withdrawal (p<0.001), procedure performed by young radialist 
physician (p=0.022). 
Pancholy 2008 Significant predictors of RAO: weight (p=<0.05), patency (p≤0.05).  
Pancholy 2012a Significant predictor of RAO: duration of compression (p=0.037) 
Pancholy 2012b Predictors of RAO: patent radial artery during hemostasis OR 0.03 (0.004-0.28), diabetes OR 11 (3-38), heparin OR 0.45 (0.13-1.54). 
Plante 2010 Independent predictors of RAO: bivalirudin OR 0.45 (0.11-2.06), body weight OR 2.78 (1.08-8.00), procedure ≤20 min OR 7.52 (1.57-36.0). 
Politi 2011 Significant predictors of RAO: heparin OR 0.70 (0.49-0.99). 
Ruhnau 2013 Predictors of RAO: women (66.7% in RAO vs 40.3% comparison, p=0.03), diabetes (40% vs 26%), renal insufficiency (20% vs 11%),  coronary 
intervention (13% vs 26%). Hypertension, dyslipidemia. present or past smoking, body height, age, and body mass index did not have significant 
influence. 
Shantha 2014 Lower RAO with introducer sheath: 
Propensity matched odds of RAO pre-discharge: OR 0.20 (0.13-0.32). 
Propensity matched odds of RAO at 24 hrs: OR 0.13 (0.07-0.25). 
Propensity matched odds of RAO at 30 days: OR 0.18 (0.10-0.40). 
Sreevatsa 2014 Predictors of RAO: diabetes, female, prior radial intervention, radial artery diameter, type of haemostasis, sheath-to-artery diameter ratio. 
Tuncez 2013 Predictor of RAO: low weight (p=0.01). 
Uhlemann 2012a Predictors of RAO: female sex OR 2.36 (1.50-3.73), 6 Fr sheath OR 2.68 (1.56-4.59), peripheral arterial occlusive disease OR 2.04 (1.02-4.22), age OR 
0.96 (0.94-0.98). 
Uhlemann 2012b Significant risk factors for RAO: 6F sheath OR 2.742 (1.574-4.776), age (10 yrs) OR 0.663 (0.523-0.842), female OR 2.591 (1.575-4.264), peripheral 
arterial disease OR 2.936 (1.300-6.632). 
Zhou 2007 Predictors of RAO: male OR 1.692 (0.837-3.156), smoking OR 1.157 (0.685-1.736), diabetes OR 0.633 (0.352-1.107), previous transradial intervention 
OR 0.728 (0.403-1.076), 7F catheter OR 5.063 (2.010-12.634), compression time >90 min OR 2.319 (1.218-4.657), pre-coated hydrophillic catheter OR 
1.781 (1.355-2.369). 
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